Kearny Financial Corp.
NASDAQ:KRNYBanks - Regional
+$0.02 today
- Market cap
- $575.92M
- Beta
- 0.64
- P/E (TTM)
- 14.7
- EPS (TTM)
- $0.57
- Dividend yield
- 5.23%
Volume 0.84M
Average 0.33M
KRNY Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Kearny Financial Corp.NASDAQ: KRNY
Research & Development · Q3 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 0 | — |
| FY2024 | 2024-06-30 | 0 | — |
| FY2023 | 2023-06-30 | 0 | — |
| FY2022 | 2022-06-30 | 0 | — |
| FY2021 | 2021-06-30 | 0 | — |
Research & Development vs competitors
How KRNY compares with its peers on the latest reported figures
- KRNY's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for KRNY, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding KRNY) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for KRNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 256.06M | 240.21M | 296.48M | 326.88M | 343.53M |
| Cost of Revenue | 48.73M | 22.15M | 120.35M | 192.5M | 191.9M |
| Gross Profit | 207.33M | 218.06M | 176.13M | 134.38M | 151.63M |
| Gross Margin | 81.0% | 90.8% | 59.4% | 41.1% | 44.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 75.89M | 82.91M | 84.21M | 78.1M | 80.01M |
| Operating Expenses | 122.83M | 125.71M | 123.75M | 215.15M | 120.63M |
| Depreciation & Amortization | 6.84M | 6.66M | 6.3M | 5.26M | 4.88M |
| EBITDA | 91.34M | 99M | 58.68M | (75.52M) | 35.88M |
| EBITDA Margin | 35.7% | 41.2% | 19.8% | -23.1% | 10.4% |
| Operating Income | 84.5M | 92.35M | 52.38M | (80.78M) | 31M |
| Operating Margin | 33.0% | 38.4% | 17.7% | -24.7% | 9.0% |
| Interest Income | 238.09M | 226.27M | 293.72M | 328.87M | 324.48M |
| Interest Expense | 49.85M | 29.67M | 117.86M | 186.27M | 189.53M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 84.5M | 92.35M | 52.38M | (80.78M) | 31M |
| Pre-Tax Margin | 33.0% | 38.4% | 17.7% | -24.7% | 9.0% |
| Income Tax Expense | 21.26M | 24.8M | 11.57M | 5.89M | 4.92M |
| Net Income | 63.23M | 67.55M | 40.81M | (86.67M) | 26.08M |
| Net Margin | 24.7% | 28.1% | 13.8% | -26.5% | 7.6% |
| EPS (Basic) | 0.77 | 0.95 | 0.63 | (1.39) | 0.42 |
| EPS (Diluted) | 0.77 | 0.95 | 0.63 | (1.39) | 0.42 |
| Weighted Avg Shares | 82.39M | 70.91M | 64.8M | 62.44M | 62.51M |
| Weighted Avg Shares (Diluted) | 82.39M | 70.93M | 64.8M | 62.44M | 62.72M |
Kearny Financial Corp.
NASDAQ:KRNY
Intrinsic Alpha fair value
Locked
Current Price
$8.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.